This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
TYVERB — Description, Dosage, Side Effects | PillsCard
OTC
TYVERB
INN: TYVERB
Data updated: 2026-04-11
Available in:
🇩🇪🇬🇧🇪🇸
Form
—
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
Novartis Europharm Limited (ES)
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Source
CIMA_ES
USDailyMed:Lapatinib
AU:C
L01EH01(WHO)
AU:S4(Prescription only)CA:℞-onlyUK:POM(Prescription only)US:℞-onlyEU:Rx-onlyIn general: ℞ (Prescription only)
N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine
231277-92-2Nas salt:388082-78-8N
208908
5692
DB01259Yas salt:DBSALT001785Y
181006Yas salt:9731817Y
0VUA21238Fas salt:G873GX646RY
D08108Nas salt:D04024N
CHEBI:49603Y
ChEMBL554Yas salt:ChEMBL1201179Y
FMM (PDBe,RCSB PDB)
DTXSID7046675
Interactive image
CS(=O)(=O)CCNCc1ccc(o1)c2ccc3c(c2)c(ncn3)Nc4ccc(c(c4)Cl)OCc5cccc(c5)F
InChI=1S/C29H26ClFN4O4S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35)YKey:BCFGMOOMADDAQU-UHFFFAOYSA-NY
Lapatinib(INN), used in the form oflapatinibditosylate(USAN) (trade namesTykerbandTyverbmarketed byNovartis) is an orally activedrugforbreast cancerand othersolid tumours.It is a dualtyrosine kinase inhibitorwhich interrupts theHER2/neuandepidermal growth factor receptor(EGFR) pathways.It is used incombination therapyfor HER2-positive breast cancer. It is used for the treatment of patients with advanced ormetastatic breast cancerwhose tumors overexpress HER2 (ErbB2).
